Conduit Pharmaceuticals Inc (CDT) Stock Price, Quote & News

Company Profile

CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has stra...

Industry: Biotechnology

Sector: Healthcare

Phone: 646 491 9132

Website: www.conduitpharma.com

Address:

4581 Tamiami Trail North, Suite 200, Naples, United States

Nevilhch Feb. 23 at 4:20 PM

$CDT Virtu Financial LLC bought 15,636 shares today. This financial company is one I follow because it does algorithmic trading... let the party begin already!

1 · Reply

MrShubby Feb. 23 at 3:01 PM

$CDT @Sam201 did you mention the most the next RS can be is 1:2?

1 · Reply

__ChartMenace Feb. 23 at 12:45 PM

$LGCL $JYD $CDT $MOVE.X 0

0 · Reply

Nevilhch Feb. 23 at 9:40 AM

$CDT CDT filed a Schedule 13G for Dominion Capital LLC for having a 5% stake in the company, and they didn't even ask @MrShubby and me, who own 50%... what a lack of respect... lol... we have to take it with a grain of salt, Mr., because honestly, they all deserve to be shot

0 · Reply

MihawkSwings Feb. 23 at 4:22 AM

Keep eyes on ticker MSS. Top watch tomorrow. MSS most likely goes up this week. Chart is looking fire. MSS low float penny sitting at bottom, getting ready to run back up. $VNDA $CDT $NCI $SGN watching.

0 · Reply

falcon630 Feb. 23 at 3:14 AM

$CDT watched this on Friday. What a pos

0 · Reply

OfficialStocktwitsUser Feb. 22 at 9:54 PM

$CDT RSI: 36.32, MACD: -0.1318 Vol: 0.12, MA20: 1.09, MA50: 1.36 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

1 · Reply

UgoGreg Feb. 22 at 8:47 PM

$CDT https://youtu.be/nCPt9XhiRxk

0 · Reply

MihawkSwings Feb. 22 at 6:58 PM

$MSS Big eyes are on this. Make sure to keep eyes on MSS. $CDT $VNDA $SGN $AIOS. paid last week.

0 · Reply

UgoGreg Feb. 22 at 5:20 PM

$CDT https://youtu.be/VcWJkTGHJVM

0 · Reply

CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy

Jan 2, 2026, 8:30 AM EST - 7 weeks ago

CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy

Oct 17, 2025, 8:30 AM EDT - 4 months ago

CDT Equity Increases Bitcoin Holding

Oct 9, 2025, 8:00 AM EDT - 4 months ago

CDT Equity Inc. Announces Reverse Stock Split

Sep 17, 2025, 8:30 AM EDT - 5 months ago

CDT Executes Cryptocurrency Treasury Reserve Strategy

Aug 26, 2025, 8:30 AM EDT - 6 months ago

CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy

Aug 5, 2025, 8:30 AM EDT - 7 months ago

Conduit to Change Name to CDT Equity Inc.

Jul 8, 2025, 8:30 AM EDT - 8 months ago

Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

Jul 7, 2025, 8:30 AM EDT - 8 months ago

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Jun 4, 2025, 8:30 AM EDT - 9 months ago

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

May 22, 2025, 8:30 AM EDT - 9 months ago

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

May 21, 2025, 8:30 AM EDT - 9 months ago

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

May 16, 2025, 8:30 AM EDT - 10 months ago

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

May 9, 2025, 8:30 AM EDT - 10 months ago

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

May 8, 2025, 8:30 AM EDT - 10 months ago

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

Apr 16, 2025, 8:30 AM EDT - 11 months ago

Conduit Pharmaceuticals Announces Leadership Changes

Apr 11, 2025, 8:30 AM EDT - 11 months ago

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

Mar 31, 2025, 8:30 AM EDT - 11 months ago

Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

Mar 6, 2025, 9:35 AM EST - 1 year ago

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel

Feb 20, 2025, 8:00 AM EST - 1 year ago

Conduit Progresses Phase II of its AI Initiative with Sarborg

Feb 13, 2025, 8:00 AM EST - 1 year ago

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

Feb 11, 2025, 9:00 AM EST - 1 year ago

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note

Feb 7, 2025, 8:00 AM EST - 1 year ago

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development

Jan 28, 2025, 5:30 AM EST - 1 year ago

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Dec 12, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Nov 21, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

Nov 19, 2024, 4:30 PM EST - 1 year ago

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

Nov 4, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline

Nov 1, 2024, 4:45 PM EDT - 1 year ago

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

Aug 12, 2024, 7:00 AM EDT - 1 year ago

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Aug 8, 2024, 6:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

May 22, 2024, 7:00 AM EDT - 1 year ago

AstraZeneca furthers ambition to transform outcomes in early lung cancer and redefine metastatic breast cancer treatment at ASCO 2024

AZN

May 21, 2024, 8:00 AM EDT - 1 year ago

Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO

Mar 19, 2024, 7:00 AM EDT - 2 years ago

Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer

Mar 11, 2024, 7:00 AM EDT - 2 years ago

Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub

Jan 31, 2024, 8:30 AM EST - 2 years ago

Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference

Oct 11, 2023, 8:30 AM EDT - 2 years ago

Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656

Oct 11, 2023, 8:30 AM EDT - 2 years ago

ClinConnect Partners with Conduit Pharmaceuticals on Cocrystal Development Program for AZD1656

Sep 22, 2023, 9:01 AM EDT - 2 years ago

Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination

Nevilhch Feb. 23 at 4:20 PM

$CDT Virtu Financial LLC bought 15,636 shares today. This financial company is one I follow because it does algorithmic trading... let the party begin already!

1 · Reply

MrShubby Feb. 23 at 3:01 PM

$CDT @Sam201 did you mention the most the next RS can be is 1:2?

1 · Reply

__ChartMenace Feb. 23 at 12:45 PM

$LGCL $JYD $CDT $MOVE.X 0

0 · Reply

Nevilhch Feb. 23 at 9:40 AM

0 · Reply

MihawkSwings Feb. 23 at 4:22 AM

0 · Reply

falcon630 Feb. 23 at 3:14 AM

$CDT watched this on Friday. What a pos

0 · Reply

OfficialStocktwitsUser Feb. 22 at 9:54 PM

1 · Reply

UgoGreg Feb. 22 at 8:47 PM

$CDT https://youtu.be/nCPt9XhiRxk

0 · Reply

MihawkSwings Feb. 22 at 6:58 PM

$MSS Big eyes are on this. Make sure to keep eyes on MSS. $CDT $VNDA $SGN $AIOS. paid last week.

0 · Reply

UgoGreg Feb. 22 at 5:20 PM

$CDT https://youtu.be/VcWJkTGHJVM

0 · Reply

WIZARDTRADING Feb. 22 at 12:54 AM

$CDT this stock lmao

0 · Reply

ChartChartist Feb. 21 at 5:17 PM

$RMSG hell of a pump im so proud of u Pumpers are heros $CDT banked well on this. 1-1.2 ; will do it again after rs and drop back to $1 the next time $FRGT frisky wants a run $MSS is running first tho; hell play em both. Slap and sell. Mss top play

0 · Reply

topstockalerts Feb. 21 at 2:38 PM

After Hours Top Gainers PT2 $BTOC $KXIN $TAOX $CDT $EMPD

0 · Reply

PurplePineApples Feb. 21 at 2:06 AM

$CDT put you on watch

0 · Reply

Sam201 Feb. 21 at 1:02 AM

$CDT you see the panic among shorts towards closing. Anything is possible here…

1 · Reply

Sam201 Feb. 20 at 9:58 PM

$CDT 2k more ..6k shares total!

0 · Reply

CW630 Feb. 20 at 8:15 PM

$CDT Definitely makes you think something is coming after hours.

3 · Reply

Nevilhch Feb. 20 at 8:04 PM

$CDT What a mess... I don't even know what to think anymore. Fucking shitty company

2 · Reply

ka1954 Feb. 20 at 7:58 PM

$CDT if this was done last year, may be stock would have done something different but this year all AI is trash except NVDA

0 · Reply

prismmarketview Feb. 20 at 7:00 PM

CDT Equity $CDT Shares Slide After $115 Million Stake Deal in AI Firm https://prismmarketview.com/cdt-equity-shares-slide-after-115-million-stake-deal-in-ai-firm/

1 · Reply

StevePattersonTrading Feb. 20 at 6:19 PM

$CDT $CDIO killed these tow trades today still have $RXT open but I dont expect that to drop till late this afternoon on a Friday

1 · Reply

max315 Feb. 20 at 6:13 PM

$CDT not sure if the professor ever joined in but it certainly acted like one of his plays.

0 · Reply

Market Cap	5.41M
Revenue (ttm)	0.00
Net Income (ttm)	-17.80M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	109,702
Avg Vol	422,744
Day's Range	N/A - N/A
Shares Out	2.93M
Stochastic %K	5%
Beta	1.93
Analysts	Strong Buy
Price Target	N/A